The company’s gross profit totaled $41.5 million, up from 2012’s $38 million. In the first six months of the year, Exactech’s revenue has increased from $113.8 million to $119.9 million, or 5 percent.
So far this year, knee, extremity and hip implant revenue all decreased. However, biologics and spine revenue jumped 6 percent to $12.9 million.
More Articles on Devices:
8 New Spine, Orthopedic Device Launches & Releases
Ceiling-Mounted CT Device Receives FDA Market Approval
Dr. Donald Gajewski Develops IDEO Device to Help Injured Soldiers Walk, Run Again
